Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      dsm-firmenich provides additional pro forma financial information for 2022 and 2023


      News provided by

      dsm-firmenich

      04 Oct, 2023, 05:00 GMT


      This image opens in the lightbox
      dsm-firmenich logo

      KAISERAUGST, Switzerland and HEERLEN, Netherlands, Oct. 4, 2023 /PRNewswire/ -- dsm-firmenich, innovators in nutrition, health, and beauty, provides additional pro forma financial information for 2022 and 2023.

      The historical pro forma financials are prepared as a combination of the historical figures reported by DSM N.V. and Firmenich SA.

      The historical pro forma financials are unaudited and include estimates and approximations.

      FY 2022 pro forma financials (updated as of October 4, 2023)


      Net sales

      2021

      2022

      2022

      2022

      2022

      2022

      2022

      2022

      (in € millions)

      FY

      Q1

      Q2

      H1

      Q3

      Q4

      H2

      FY

      P&B


      932

      953

      1,885

      991

      916

      1,907

      3,792

      TTH


      735

      797

      1,532

      836

      806

      1,642

      3,174

      HNC


      592

      613

      1,205

      626

      587

      1,213

      2,418

      ANH


      882

      953

      1,835

      978

      971

      1,949

      3,784

      Corporate


      21

      19

      40

      15

      15

      30

      70

      dsm-firmenich

      11,444

      3,162

      3,335

      6,497

      3,446

      3,295

      6,741

      13,238










      Adj. EBITDA

      2021

      2022

      2022

      2022

      2022

      2022

      2022

      2022

      (in € millions)

      FY

      Q1

      Q2

      H1

      Q3

      Q4

      H2

      FY

      P&B


      201

      164

      365

      217

      166

      383

      748

      TTH


      135

      136

      271

      141

      137

      278

      549

      HNC


      126

      142

      268

      144

      121

      265

      533

      ANH


      155

      158

      313

      116

      95

      211

      524

      Corporate


      (22)

      (18)

      (40)

      (19)

      (20)

      (39)

      (79)

      dsm-firmenich

      2,200

      595

      582

      1,177

      599

      499

      1,098

      2,275










      Adj. EBITDA margin

      2021

      2022

      2022

      2022

      2022

      2022

      2022

      2022

      ( %)

      FY

      Q1

      Q2

      H1

      Q3

      Q4

      H2

      FY

      P&B


      21.6 %

      17.2 %

      19.4 %

      21.9 %

      18.1 %

      20.1 %

      19.7 %

      TTH


      18.4 %

      17.1 %

      17.7 %

      16.9 %

      17.0 %

      16.9 %

      17.3 %

      HNC


      21.3 %

      23.2 %

      22.2 %

      23.0 %

      20.6 %

      21.8 %

      22.0 %

      ANH


      17.6 %

      16.6 %

      17.1 %

      11.9 %

      9.8 %

      10.8 %

      13.8 %

      Corporate









      dsm-firmenich

      19.2 %

      18.8 %

      17.5 %

      18.1 %

      17.4 %

      15.1 %

      16.3 %

      17.2 %

      Methodology

      The 2022 pro forma financials are prepared as a combination of the historical figures reported by DSM N.V. and Firmenich SA.
      The 2022 pro forma financials are unaudited and include estimates, including for example approximations due to the different reporting currencies. The reporting currency of dsm-firmenich is EUR.
      The following reporting perimeter changes and adjustments are applied:
      - Changes to the Business Units' reporting perimeters: combination of the units T&B and F&B in TTH; Personal Care & Aroma (PCA) transfer to P&B from HNC; other minor adjustments including the Consumer Healthcare business transfer from T&B to HNC.
      - Intercompany profit elimination: HNC net sales were reduced by approximately €50m to eliminate ingredient sales to Firmenich.

      Further information for the basis of preparation of the pro forma financials and related definitions can be found in the H1 2023 results press release.

      FY 2022 pro forma EBITDA to Core Adjusted EPS walk



      2022

      2022

      2022


      H1

      H2

      FY





      Sales

      6,497

      6,741

      13,238





      EBITDA

      1,031

      988

      2,019

      APMs

      146

      110

      256





      Adjusted EBITDA

      1,177

      1,098

      2,275

      Adjusted EBITDA %

      18.1 %

      16.3 %

      17.2 %





      D&A

      (437)

      (477)

      (914)





      EBIT

      594

      517

      1,111

      APMs

      146

      104

      250





      Adjusted EBIT

      740

      621

      1,361





      PPA

      -

      -

      -





      Core Adjusted EBIT

      740

      621

      1,361





      Fin ex

      (66)

      (93)

      (159)





      Core Adjusted PBT

      674

      528

      1,202





      Tax

      (132)

      (94)

      (226)

      Tax %

      20 %

      18 %

      19 %





      Share from associates

      32

      5

      37





      Core Adjusted Net profit

      574

      439

      1,013





      Non-controlling interest

      8

      9

      17





      Avg outstanding shares

      264

      265

      265





      Core Adjusted EPS

      2.14

      1.62

      3.76

      H1 2023 pro forma financials (updated as of October 4, 2023)


      Net sales

      2023

      2023

      2023

      (in € millions)

      Q1

      Q2

      H1

      P&B

      972

      903

      1,875

      TTH

      772

      761

      1,533

      HNC

      582

      562

      1,144

      ANH

      785

      786

      1,571

      Corporate

      11

      18

      29

      dsm-firmenich

      3,122

      3,030

      6,152





      Adj. EBITDA

      2023

      2023

      2023

      (in € millions)

      Q1

      Q2

      H1

      P&B

      210

      169

      379

      TTH

      152

      137

      289

      HNC

      120

      100

      220

      ANH

      68

      17

      85

      Corporate

      (29)

      (15)

      (44)

      dsm-firmenich

      521

      408

      929





      Adj. EBITDA margin

      2023

      2023

      2023

      ( %)

      Q1

      Q2

      H1

      P&B

      21.6 %

      18.7 %

      20.2 %

      TTH

      19.7 %

      18.0 %

      18.9 %

      HNC

      20.6 %

      17.8 %

      19.2 %

      ANH

      8.7 %

      2.2 %

      5.4 %

      Corporate




      dsm-firmenich

      16.7 %

      13.5 %

      15.1 %

      About dsm-firmenich 
      As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people.
      www.dsm-firmenich.com 

      For more information

      Media
      e-mail media@dsm-firmenich.com

      Investors
      e-mail investors@dsm-firmenich.com

      Forward-looking statements
      This press release may contain forward-looking statements with respect to dsm-firmenich's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of this press release prevails over other language versions.

      Logo - https://mma.prnewswire.com/media/2071772/dsm_firmenich_Logo.jpg

      Modal title

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.